查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1679569

眼药水市场规模、份额、趋势分析报告：按类型、药物类型、治疗类型、地区和细分市场预测，2025-2030 年

Ophthalmic Eye Dropper Market Size, Share & Trends Analysis Report By Type (Unidose, Preserved, Preservative-free), By Drug Type (Prescription Drugs, OTC Drugs), By Treatment Type (Glaucoma, Allergies), By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 150 Pages | 商品交期: 2-10个工作天内

价格

眼药水市场的成长与趋势

预计到 2030 年全球眼药水市场规模将达到 200.2 亿美元，2025 年至 2030 年的复合年增长率为 6.1%。

青光眼、老龄化黄斑部病变和眼部眼科疾病的盛行率在全球范围内不断上升，导致对有效眼药水治疗的需求激增。此外，药物传递技术的进步和不含防腐剂的眼药水的推出显着提高了患者对治疗方法的依从性。例如，不含防腐剂的眼药水被认为更安全，并且受到干眼症患者的青睐，因此可以更频繁地使用。

白内障、青光眼、干眼症、过敏等眼科疾病的增多，大大增加了眼药水的需求。例如，美国国家青光眼研究报告显示，超过 300 万美国人患有青光眼，其中 270 万人患有开放性青光眼，这种疾病在 40 岁以上的人中更为常见。盛行率的快速上升与世界人口老化相吻合，导致这些疾病的发生率不断上升。因此，迫切需要眼药水等有效的治疗方法。

人们对保持最佳眼部健康和定期进行眼部检查的认识不断提高，推动了对眼药水的需求。这种积极主动的方法有助于儘早治疗眼部问题，从而为眼科护理提供者和眼药水製造商提供帮助。例如，爱尔康和博士伦等公司针对各种眼部问题生产特殊眼药水，推动市场成长。

眼药水市场报告重点

  • 市场正处于中等成长阶段，由于技术、配方和眼药水传输系统等多种因素的进步，其成长速度正在加快。
  • 2024年，保存型多剂量眼药水部分占最大收益占有率，为48.5%。
  • 处方药部分预计将在 2024 年占据最大的收益占有率，达到 61.3%，并有望在 2025 年至 2030 年期间实现最快的复合年增长率。
  • 2024 年，干眼症领域占据了最大的市场占有率。这是因为长时间使用数位设备、环境因素和人口老化增加了使用滴管进行特殊治疗的需求。
  • 到 2024 年，北美眼药水市场将占据全球市场的 44.75%。

目录

第一章调查方法与范围

第二章执行摘要

第三章眼药水市场变数、趋势与范围

  • 市场体系展望
    • 母市场展望
    • 相关/辅助市场展望
  • 市场动态
    • 市场驱动因素分析
    • 市场限制因素分析
  • 眼药水市场分析工具
    • 产业分析—波特五力分析
    • PESTEL分析

第四章 眼药水市场：依类型估算与趋势分析

  • 定义和范围
    • 单剂量眼药水
    • 储存多剂量眼药水
    • 不含防腐剂的多剂量眼药水
  • 2024 年及 2030 年各类型市场占有率
  • 细分仪表板
  • 全球眼药水市场类型预测
  • 2018-2030年市场规模、预测及趋势分析
    • 单剂量眼药水
    • 储存的多剂量眼药水
    • 不含防腐剂的多剂量眼药水

第五章 眼药水市场：依药物类型估算与趋势分析

  • 定义和范围
    • 处方药
    • 非处方药
  • 2024 年和 2030 年各药物类型的市场占有率
  • 细分仪表板
  • 全球眼药水市场（依药物类型）预测
  • 2018-2030年市场规模、预测及趋势分析
    • 处方药
    • 非处方药

第六章 眼药水市场：依治疗类型分類的估计与趋势分析

  • 定义和范围
    • 眼睛干涩
    • 青光眼
    • 过敏
    • 结膜炎
    • 其他的
  • 2024 年和 2030 年各治疗类型的市场占有率
  • 细分仪表板
  • 全球眼药水市场（依治疗类型）预测
  • 2018-2030年市场规模、预测及趋势分析
    • 眼睛干涩
    • 青光眼
    • 过敏
    • 结膜炎
    • 其他的

第七章眼药水市场：区域、估计与趋势分析

  • 2024 年及 2030 年区域市场占有率分析
  • 区域市场仪表板
  • 全球区域市场概述
  • 2018-2030年市场规模及预测趋势分析
  • 北美洲
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 义大利
    • 西班牙
    • 挪威
    • 瑞典
    • 丹麦
  • 亚太地区
    • 日本
    • 中国
    • 印度
    • 澳洲
    • 韩国
    • 泰国
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中东和非洲
    • 南非
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 科威特

第八章竞争格局

  • 主要市场参与企业的近期趋势和影响分析
  • 公司/竞争对手分类
    • 创新者
  • 供应商格局
    • 主要经销商和通路合作伙伴名单
    • 2024年主要企业市场占有率分析
    • AptarGroup, Inc
    • Silgan Dispensing Systems
    • Alcon plc
    • Pfizer
    • Bausch & Lomb Incorporated
    • Novartis AG
    • AbbVie Inc
    • Santen Pharmaceutical Co., Ltd.
    • Johnson & Johnson Vision
    • Similasan Corporation
Product Code: GVR-4-68040-187-8

Ophthalmic Eye Dropper Market Growth & Trends:

The global ophthalmic eye dropper market size is anticipated to reach USD 20.02 billion in 2030 and is anticipated to grow at a CAGR of 6.1% from 2025 to 2030. The rising prevalence of eye disorders such as glaucoma, age-related macular degeneration, and eye syndrome among the aging population worldwide has surged the demand for efficient treatments delivered through eye droppers. Moreover, advancements in drug delivery technologies and the introduction of preservative-free eye drops have notably improved patient adherence to treatment regimens. For instance, preservative-free drops are considered safer and preferred by individuals with dry eyes, thus allowing more frequent use.

The rise in eye conditions such as cataracts, glaucoma, dry eye syndrome, and allergies has significantly bolstered the demand for ophthalmic eye drops. For instance, as reported by the National Glaucoma Research, over 3 million Americans live with glaucoma, out of which 2.7 million are affected by the prevalent open-angle glaucoma among those aged 40 and older. This surge in prevalence aligns with the aging global population, contributing to the increasing occurrence of these conditions. Consequently, there's a pressing necessity for effective treatments like eye drops to address these escalating eye health challenges.

The increased awareness about maintaining optimal eye health and regular eye check-ups has improved the demand for ophthalmic eye drops. This proactive approach helps treat ophthalmic issues quicker which allows eye care providers and eye drops manufacturing companies to assist. For instance, companies like Alcon and Bausch + Lomb have made special eye drops for different eye problems, thereby fueling the market growth.

Ophthalmic Eye Dropper Market Report Highlights:

  • The market growth stage is medium, and the pace is identified as accelerating owing to several factors, such as advancements in technology, formulations, and delivery systems for ophthalmic eye drops, which have significantly contributed to this growth.
  • The preserved multi-dose eye droppers segment accounted for the largest revenue share of 48.5% in 2024.
  • The prescription drugs segment accounted for the largest revenue share of 61.3% in 2024 and is expected to attain the fastest CAGR from 2025 to 2030.
  • The dry eye segment accounted for the largest market share in 2024, due to prolonged digital device use, environmental factors, and an aging population, which has heightened the need for specific treatments administered via eye droppers.
  • North America ophthalmic eye dropper market dominated the global market 44.75% in 2024.

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Drug Type
    • 1.1.3. Treatment
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database.
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
      • 1.3.5.1. Data for Primary Interviews in North America
      • 1.3.5.2. Data for Primary Interviews in Europe
      • 1.3.5.3. Data for Primary Interviews in Asia Pacific
      • 1.3.5.4. Data for Primary Interviews in Latin America
      • 1.3.5.5. Data for Primary Interviews in MEA
  • 1.4. Information or Data Analysis
    • 1.4.1. Data analysis models
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
    • 1.6.1. Commodity flow analysis (Model 1)
      • 1.6.1.1. Approach 1: Commodity flow approach
    • 1.6.2. Volume price analysis (Model 2)
      • 1.6.2.1. Approach 2: Volume price analysis
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Drug Type
    • 2.2.3. Treatment Type
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Ophthalmic Eye Dropper Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook.
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing prevalence of eye disorders
      • 3.2.1.2. Technological advancements in drug delivery systems
      • 3.2.1.3. Aging population and lifestyle changes
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. Limited patient compliance
  • 3.3. Ophthalmic Eye Dropper Market Analysis Tools
    • 3.3.1. Industry Analysis - Porter's
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTEL Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Technological landscape
      • 3.3.2.3. Economic landscape

Chapter 4. Ophthalmic Eye Dropper Market: Type Estimates & Trend Analysis

  • 4.1. Definitions and Scope
    • 4.1.1. Unidose eye droppers
    • 4.1.2. Preserved multi-dose eye droppers
    • 4.1.3. Preservative-free multi-dose eye droppers
  • 4.2. Type Market Share, 2024 & 2030
  • 4.3. Segment Dashboard
  • 4.4. Global Ophthalmic Eye Dropper Market by Type Outlook
  • 4.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 4.5.1. Unidose eye droppers
      • 4.5.1.1. Unidose eye Droppers Market Estimates and Forecast 2018 to 2030 (USD Million)
    • 4.5.2. Preserved multi-dose eye droppers
      • 4.5.2.1. Preserved multi-dose eye droppers market estimates and forecast 2018 to 2030 (USD Million)
    • 4.5.3. Preservative-free multi-dose eye droppers
      • 4.5.3.1. Preservative-free multi-dose eye Droppers Market Estimates and forecast 2018 to 2030 (USD Million)

Chapter 5. Ophthalmic Eye Dropper Market: Drug Type Estimates & Trend Analysis

  • 5.1. Definitions and Scope
    • 5.1.1. Prescription drugs
    • 5.1.2. OTC drugs
  • 5.2. Drug Type Market Share, 2024 & 2030
  • 5.3. Segment Dashboard
  • 5.4. Global Ophthalmic Eye Dropper Market by Drug Type Outlook
  • 5.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 5.5.1. Prescription drugs
      • 5.5.1.1. Prescription drugs market estimates and forecast 2018 to 2030 (USD Million)
    • 5.5.2. OTC drugs
      • 5.5.2.1. OTC drugs market estimates and forecast 2018 to 2030 (USD Million)

Chapter 6. Ophthalmic Eye Dropper Market: Treatment Type Estimates & Trend Analysis

  • 6.1. Definitions and Scope
    • 6.1.1. Dry Eye
    • 6.1.2. Glaucoma
    • 6.1.3. Allergies
    • 6.1.4. Conjunctivitis
    • 6.1.5. Others
  • 6.2. Treatment Type Market Share, 2024 & 2030
  • 6.3. Segment Dashboard
  • 6.4. Global Ophthalmic Eye Dropper Market by Treatment Type Outlook
  • 6.5. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
    • 6.5.1. Dry Eye
      • 6.5.1.1. Dry eye market estimates and forecasts for 2018 to 2030 (USD Million)
    • 6.5.2. Glaucoma
      • 6.5.2.1. Glaucoma market estimates and forecasts for 2018 to 2030 (USD Million)
    • 6.5.3. Allergies
      • 6.5.3.1. Allergies market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.4. Conjunctivitis
      • 6.5.4.1. Conjunctivitis market estimates and forecast 2018 to 2030 (USD Million)
    • 6.5.5. Others
      • 6.5.5.1. Others market estimates and forecast 2018 to 2030 (USD Million)

Chapter 7. Ophthalmic Eye Dropper Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Market Share Analysis, 2024 & 2030
  • 7.2. Regional Market Dashboard
  • 7.3. Global Regional Market Snapshot
  • 7.4. Market Size & Forecasts Trend Analysis, 2018 to 2030:
  • 7.5. North America
    • 7.5.1. U.S.
      • 7.5.1.1. Key country dynamics
      • 7.5.1.2. Competitive scenario
      • 7.5.1.3. Regulatory framework
      • 7.5.1.4. Reimbursement scenario
      • 7.5.1.5. U.S. market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.2. Canada
      • 7.5.2.1. Key country dynamics
      • 7.5.2.2. Competitive scenario
      • 7.5.2.3. Regulatory framework
      • 7.5.2.4. Reimbursement scenario
      • 7.5.2.5. Canada market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.5.3. Mexico
      • 7.5.3.1. Key country dynamics
      • 7.5.3.2. Competitive scenario
      • 7.5.3.3. Regulatory framework
      • 7.5.3.4. Reimbursement scenario
      • 7.5.3.5. Mexico market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.6. Europe
    • 7.6.1. UK
      • 7.6.1.1. Key country dynamics
      • 7.6.1.2. Competitive scenario
      • 7.6.1.3. Regulatory framework
      • 7.6.1.4. Reimbursement scenario
      • 7.6.1.5. UK market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.2. Germany
      • 7.6.2.1. Key country dynamics
      • 7.6.2.2. Competitive scenario
      • 7.6.2.3. Regulatory framework
      • 7.6.2.4. Reimbursement scenario
      • 7.6.2.5. Germany market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.3. France
      • 7.6.3.1. Key country dynamics
      • 7.6.3.2. Competitive scenario
      • 7.6.3.3. Regulatory framework
      • 7.6.3.4. Reimbursement scenario
      • 7.6.3.5. France market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.4. Italy
      • 7.6.4.1. Key country dynamics
      • 7.6.4.2. Competitive scenario
      • 7.6.4.3. Regulatory framework
      • 7.6.4.4. Reimbursement scenario
      • 7.6.4.5. Italy market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.5. Spain
      • 7.6.5.1. Key country dynamics
      • 7.6.5.2. Competitive scenario
      • 7.6.5.3. Regulatory framework
      • 7.6.5.4. Reimbursement scenario
      • 7.6.5.5. Spain market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.6. Norway
      • 7.6.6.1. Key country dynamics
      • 7.6.6.2. Competitive scenario
      • 7.6.6.3. Regulatory framework
      • 7.6.6.4. Reimbursement scenario
      • 7.6.6.5. Norway market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.7. Sweden
      • 7.6.7.1. Key country dynamics
      • 7.6.7.2. Competitive scenario
      • 7.6.7.3. Regulatory framework
      • 7.6.7.4. Reimbursement scenario
      • 7.6.7.5. Sweden market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.6.8. Denmark
      • 7.6.8.1. Key country dynamics
      • 7.6.8.2. Competitive scenario
      • 7.6.8.3. Regulatory framework
      • 7.6.8.4. Reimbursement scenario
      • 7.6.8.5. Denmark market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.7. Asia Pacific
    • 7.7.1. Japan
      • 7.7.1.1. Key country dynamics
      • 7.7.1.2. Competitive scenario
      • 7.7.1.3. Regulatory framework
      • 7.7.1.4. Reimbursement scenario
      • 7.7.1.5. Japan market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.2. China
      • 7.7.2.1. Key country dynamics
      • 7.7.2.2. Competitive scenario
      • 7.7.2.3. Regulatory framework
      • 7.7.2.4. Reimbursement scenario
      • 7.7.2.5. China market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.3. India
      • 7.7.3.1. Key country dynamics
      • 7.7.3.2. Competitive scenario
      • 7.7.3.3. Regulatory framework
      • 7.7.3.4. Reimbursement scenario
      • 7.7.3.5. India market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.4. Australia
      • 7.7.4.1. Key country dynamics
      • 7.7.4.2. Competitive scenario
      • 7.7.4.3. Regulatory framework
      • 7.7.4.4. Reimbursement scenario
      • 7.7.4.5. Australia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.5. South Korea
      • 7.7.5.1. Key country dynamics
      • 7.7.5.2. Competitive scenario
      • 7.7.5.3. Regulatory framework
      • 7.7.5.4. Reimbursement scenario
      • 7.7.5.5. South Korea market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.7.6. Thailand
      • 7.7.6.1. Key country dynamics
      • 7.7.6.2. Competitive scenario
      • 7.7.6.3. Regulatory framework
      • 7.7.6.4. Reimbursement scenario
      • 7.7.6.5. Thailand market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.8. Latin America
    • 7.8.1. Brazil
      • 7.8.1.1. Key country dynamics
      • 7.8.1.2. Competitive scenario
      • 7.8.1.3. Regulatory framework
      • 7.8.1.4. Reimbursement scenario
      • 7.8.1.5. Brazil market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.8.2. Argentina
      • 7.8.2.1. Key country dynamics
      • 7.8.2.2. Competitive scenario
      • 7.8.2.3. Regulatory framework
      • 7.8.2.4. Reimbursement scenario
      • 7.8.2.5. Argentina market estimates and forecast, 2018 - 2030 (USD Million)
  • 7.9. MEA
    • 7.9.1. South Africa
      • 7.9.1.1. Key country dynamics
      • 7.9.1.2. Competitive scenario
      • 7.9.1.3. Regulatory framework
      • 7.9.1.4. Reimbursement scenario
      • 7.9.1.5. South Africa market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.2. Saudi Arabia
      • 7.9.2.1. Key country dynamics
      • 7.9.2.2. Competitive scenario
      • 7.9.2.3. Regulatory framework
      • 7.9.2.4. Reimbursement scenario
      • 7.9.2.5. Saudi Arabia market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.3. UAE
      • 7.9.3.1. Key country dynamics
      • 7.9.3.2. Competitive scenario
      • 7.9.3.3. Regulatory framework
      • 7.9.3.4. Reimbursement scenario
      • 7.9.3.5. UAE market estimates and forecast, 2018 - 2030 (USD Million)
    • 7.9.4. Kuwait
      • 7.9.4.1. Key country dynamics
      • 7.9.4.2. Competitive scenario
      • 7.9.4.3. Regulatory framework
      • 7.9.4.4. Reimbursement scenario
      • 7.9.4.5. Kuwait market estimates and forecast, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Innovators
  • 8.3. Vendor Landscape
    • 8.3.1. List of key distributors and channel partners
    • 8.3.2. Key customers
    • 8.3.3. Key company market share analysis, 2024
    • 8.3.4. AptarGroup, Inc
      • 8.3.4.1. Company overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Silgan Dispensing Systems
      • 8.3.5.1. Company overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. Alcon plc
      • 8.3.6.1. Company overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. Pfizer
      • 8.3.7.1. Company overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Bausch & Lomb Incorporated
      • 8.3.8.1. Company overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. Novartis AG
      • 8.3.9.1. Company overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives
    • 8.3.10. AbbVie Inc
      • 8.3.10.1. Company overview
      • 8.3.10.2. Financial performance
      • 8.3.10.3. Product benchmarking
      • 8.3.10.4. Strategic initiatives
    • 8.3.11. Santen Pharmaceutical Co., Ltd.
      • 8.3.11.1. Company overview
      • 8.3.11.2. Financial performance
      • 8.3.11.3. Product benchmarking
      • 8.3.11.4. Strategic initiatives
    • 8.3.12. Johnson & Johnson Vision
      • 8.3.12.1. Company overview
      • 8.3.12.2. Financial performance
      • 8.3.12.3. Product benchmarking
      • 8.3.12.4. Strategic initiatives
    • 8.3.13. Similasan Corporation
      • 8.3.13.1. Company overview
      • 8.3.13.2. Financial performance
      • 8.3.13.3. Product benchmarking
      • 8.3.13.4. Strategic initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 4 Global ophthalmic eye dropper market, by drug type, (USD million) 2018 - 2030
  • Table 5 Global ophthalmic eye dropper market, by treatment type, (USD million) 2018 - 2030
  • Table 6 North America ophthalmic eye dropper market, by country, 2018 - 2030 (USD Million)
  • Table 7 North America ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 8 North America ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 9 North America ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 10 U.S. ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 11 U.S. ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 12 U.S. ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 13 Canada ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 14 Canada ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 15 Canada ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 16 Mexico ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 17 Mexico ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 18 Mexico ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 19 Europe ophthalmic eye dropper market, by country, 2018 - 2030 (USD Million)
  • Table 20 Europe ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 21 Europe ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 22 Europe ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 23 UK ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 24 UK ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 25 UK ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 26 Germany ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 27 Germany ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 28 Germany ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 29 France ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 30 France ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 31 France ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 32 Italy ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 33 Italy ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 34 Italy ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 35 Spain ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 36 Spain ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 37 Spain ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 38 Norway ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 39 Norway ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 40 Norway ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 41 Sweden ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 42 Sweden ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 43 Sweden ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 44 Denmark ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 45 Denmark ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 46 Denmark ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific ophthalmic eye dropper market, by country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 51 Japan ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 52 Japan ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 53 Japan ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 54 China ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 55 China ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 56 China ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 57 India ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 58 India ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 59 India ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 60 Australia ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 61 Australia ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 62 Australia ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 63 South Korea ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 64 South Korea ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 65 South Korea ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 66 Thailand ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 67 Thailand ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 68 Thailand ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 69 Latin America ophthalmic eye dropper market, by country, 2018 - 2030 (USD Million)
  • Table 70 Latin America ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 71 Latin America ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 72 Latin America ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 73 Brazil ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 74 Brazil ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 75 Brazil ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 76 Argentina ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 77 Argentina ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 78 Argentina ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa ophthalmic eye dropper market, by country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 83 South Africa ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 84 South Africa ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 85 South Africa ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 89 UAE ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 90 UAE ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 91 UAE ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)
  • Table 92 Kuwait ophthalmic eye dropper market, by type, 2018 - 2030 (USD Million)
  • Table 93 Kuwait ophthalmic eye dropper market, by drug type, 2018 - 2030 (USD Million)
  • Table 94 Kuwait ophthalmic eye dropper market, by treatment type, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 Ophthalmic eye dropper market segmentation
  • Fig. 7 Market driver analysis (Current & future impact)
  • Fig. 8 Market restraint analysis (Current & future impact)
  • Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 10 Porter's Five Forces Analysis
  • Fig. 11 Ophthalmic eye dropper market, type outlook key takeaways (USD Million)
  • Fig. 12 Ophthalmic eye dropper market: type movement analysis, 2023 & 2030 (USD Million)
  • Fig. 13 Unidose eye droppers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 14 Preserved multi-dose eye droppers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 15 Preservative-free multi-dose eye droppers market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 16 Ophthalmic eye dropper market, drug type outlook key takeaways (USD Million)
  • Fig. 17 Ophthalmic eye dropper market: Drug type movement analysis, 2023 & 2030 (USD Million)
  • Fig. 18 Prescription drugs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 OTC drugs market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 Ophthalmic eye dropper market, treatment type outlook key takeaways (USD Million)
  • Fig. 21 Ophthalmic eye dropper market: Treatment type movement analysis, 2023 & 2030 (USD Million)
  • Fig. 22 Dry eye market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 23 Glaucoma market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 24 Allergies market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Conjunctivitis market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Ophthalmic eye dropper market: Regional key takeaways (USD Million)
  • Fig. 28 Ophthalmic eye dropper market: Regional outlook, 2023 & 2030, USD Million
  • Fig. 29 North America ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 30 US ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Canada ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Mexico ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Europe ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 UK ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Germany ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 France ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Spain ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 38 Italy ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 Sweden ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Norway ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Denmark ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 Asia Pacific ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 China ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 Japan ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 India ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 South Korea ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Australia ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Thailand ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Latin America ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Brazil ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Argentina ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Middle East and Africa ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 South Africa ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Saudi Arabia ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 UAE ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 Kuwait ophthalmic eye dropper market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 List of key emerging company's/technology disruptors/innovators